sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Medical Device Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market...

Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)

TIPRE00028783 | Pages: 129 | Medical Device | Apr 2022 | Type: Regional | Status: Published

The Asia Pacific circulating tumor cell (CTC) diagnostics market is expected to reach US$ 689.3 million by 2028 from US$ 347.6 million in 2021. The market is estimated to grow at a CAGR of 10.3% from 2021 to 2028.

 

The rising demand for liquid biopsies for cancer detection is expected to boost the demand for circulating tumor cell diagnostics. Leading market players focus on enlarging their reach across emerging markets by expanding their distribution networks and augmenting manufacturing capabilities. Emerging markets in India and South Korea are expected to offer potential growth opportunities for crucial circulating tumor cell (CTC) diagnostics market players in the coming years. This can be attributed to the large patient population, high cancer prevalence (including types such as skin, breasts, lungs, pancreas, and other organs and glands), increasing disposable income, improving healthcare infrastructure, and growing medical tourism in these countries. As the markets mature, most players are shifting their focus to emerging markets. High investments in life science and health research in emerging countries play a key role in upgrading their healthcare infrastructure with the latest technologies. This factor, in turn, supports the  progress in cancer diagnostics, thereby creating new opportunities for the Asia Pacific circulating tumor cell (CTC) diagnostics market players.

 

Prohibitive measures have been taken to contain the spread of the COVID-19 pandemic in APAC countries. The pandemic has largely affected the economies of India, China, Japan, and South Korea, among others. The onset of the pandemic and exponential rise in patients with the need of hospitalization led to delays and temporary suspension of cancer screening, diagnosis, and treatment services. Moreover, government regulations, nationwide lockdowns, and spiking infection rates had a significant financial impact on healthcare facilities. Several hospitals and clinics have seen a decrease in patient visits as a result of COVID-19. The scarcity of medical care and supplies for conditions other than COVID-19 had a detrimental impact on the circulating tumor cell diagnostics market proliferation. At the same time, limited healthcare staff availability hampered the circulating tumor cell diagnostics market in Asia Pacific. In addition, the socio-economy was badly hit, with growing inflation, declining GDP, and rising unemployment in the region. The pandemic has affected three main aspects of the global economy: manufacturing, supply chain, and business and financial markets.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market. The Asia Pacific circulating tumor cell (CTC) diagnostics market is expected to grow at a good CAGR during the forecast period.

 

Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


 

Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Segmentation 

By Technology

  • CTC detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis

By Application

  • Clinical/Liquid Biopsy
    • Risk Assessment
    • Screening and Monitoring
  • Research
    • Cancer Stem Cell and Tumorigenesis Research
    • Drug/Therapy Development

By End-User

  • Hospitals and Clinics
  • Research and Academic Institutes
  • Diagnostic Centers

By Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Stemcell Technologies Inc.
  • Qiagen
  • Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  • Screencell
  • Fluxion Bioscience

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Asia Pacific PEST Analysis

4.3         Experts Opinion

5.           Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Rising Demand for Minimally Invasive Diagnostic Procedures

5.2         Market Restraints

5.2.1        Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3         Market Opportunities

5.3.1        Untapped Potential of Emerging Economies

5.4         Future Trends

5.4.1        Technological Advancements in Isolation of Circulating Tumor Cell

5.5         Impact Analysis

6.           Circulating Tumor Cell (CTC) Diagnostics Market– Asia Pacific Analysis

6.1         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

7.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology

7.1         Overview

7.2         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)

7.3         CTC detection and Enrichment Method

7.3.1        Overview

7.3.2        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.4         CTC Direct Detection Method

7.4.1        Overview

7.4.2        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.5         CTC Analysis

7.5.1        Overview

7.5.2        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application

8.1         Overview

8.2         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)

8.3         Clinical/Liquid Biopsy

8.3.1        Overview

8.3.2        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        Risk Assessment

8.3.3.1          Overview

8.3.3.2          Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Screening and Monitoring

8.3.4.1          Overview

8.3.4.2          Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Research

8.4.1        Overview

8.4.2        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1          Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1          Overview

8.4.2.1.2          Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2          Drug/Therapy Development

8.4.2.2.1          Overview

8.4.2.2.2          Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user

9.1         Overview

9.2         Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Research and Academic Institutes

9.4.1        Overview

9.4.2        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Centers

9.5.1        Overview

9.5.2        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1      Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market

10.1.1     Overview

10.1.2     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)

10.1.3     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.4     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.4.1       Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.4.2       Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.5     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6     Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1       China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1       China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2       China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.1.3       China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.1.3.1     China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.1.3.2     China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.1.4       China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.2       Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1       Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2       Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.2.3       Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.2.3.1     Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.2.3.2     Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.2.4       Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.3       India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1       India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2       India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.3.3       India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.3.3.1     India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.3.3.2     India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.3.4       India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.4       Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.1       Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.2       Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.4.3       Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.4.3.1     Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.4.3.2     Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.4.4       Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.5       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.1       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.2       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.5.3       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.5.3.1     South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.5.3.2     South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.5.4       South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

10.1.6.6       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.1       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.2       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2019–2028 (US$ Million)

10.1.6.6.3       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application, 2019–2028 (US$ Million)

10.1.6.6.3.1     Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy, 2019–2028 (US$ Million)

10.1.6.6.3.2     Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research, 2019–2028 (US$ Million)

10.1.6.6.4       Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User, 2019–2028 (US$ Million)

11.        Impact of COVID-19 Pandemic on Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market

11.1      Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      STEMCELL Technologies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      SCREENCELL

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      FLUXION BIOSCIENCES

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 7.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 8.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 9.             China: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 10.          China: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Japan: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 16.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology– Revenue and Forecast to 2028 (US$ Million)

Table 17.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Application– Revenue and Forecast to 2028 (US$ Million)

Table 18.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/ Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 19.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By Research– Revenue and Forecast to 2028 (US$ Million)

Table 20.          India: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User– Revenue and Forecast to 2028 (US$ Million)

Table 21.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Australia: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 26.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 27.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 28.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 29.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 30.          South Korea: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Technology – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Application – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Clinical/Liquid Biopsy – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By Research – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, By End-User – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 37.          Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 38.          Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

 


LIST OF FIGURES

Figure 1.           Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

Figure 2.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Overview

Figure 3.           CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market

Figure 4.           China is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)

Figure 10.        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 11.        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)

Figure 14.        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

Figure 21.        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25.        Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 27.        China: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Japan: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        India: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Australia: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        South Korea: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Rest of Asia Pacific: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 34.        Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

  1. Thermo Fisher Scientific Inc.
  2. Stemcell Technologies Inc.
  3. Qiagen
  4. Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  5. Fluxion Biosciences
  6. Screencell
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific circulating tumor cell (CTC) diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific circulating tumor cell (CTC) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription